Achieving LDL-particle targets deemed cost-effective

January 11, 2017

(HealthDay)—Achieving targets of low-density lipoprotein (LDL), as measured by LDL particle number (LDL-P) compared with LDL-cholesterol (LDL-C), is cost-effective, according to a study published in the Feb. 1 issue of The American Journal of Cardiology.

Michael Grabner, Ph.D., from HealthCore Inc. in Wilmington, Del., and examined the cost-effectiveness of LDL-lowering therapy guided by LDL-P among patients selected from the HealthCore Integrated Research Database who were followed for 12 to 36 months. The LDL-P cohort included patients who achieved LDL-P <1,000 nmol/L, while those without LDL-P tests but who achieved LDL-C <100 mg/dL were included in the LDL-C cohort. At the 12-, 24-, and 36-month follow-up, each cohort included 2,094, 1,242, and 705 patients, respectively.

The researchers found that, compared with in the LDL-C cohort, those in the LDL-P cohort received more aggressive lipid-lowering therapy and had fewer cardiovascular disease (CVD) events during follow-up. Over time, this correlated with increased pharmacy costs and lower medical costs. The incremental cost-effectiveness ratio estimates varied from $23,131, $3,439, and −$4,555 per CVD event avoided at 12, 24, and 36 months, respectively.

"LDL-lowering therapy guided by LDL-P was demonstrated to be cost-effective, with greater clinical and economic benefit seen over longer time horizons and with the increased use of generic statins," the authors write.

Several authors are employees of HealthCore, which received funding from LipoScience for the conduct of the study; two authors are employees of LipoScience.

Explore further: Fish oil supplementation tied to lower atherothrombotic risk

More information: Full Text

Related Stories

Fish oil supplementation tied to lower atherothrombotic risk

April 16, 2015
(HealthDay)—Fish oil supplementation (FOS) is associated with atherothrombotic risk reduction in suspected coronary artery disease (sCAD), according to a study published in the May 1 issue of The American Journal of Cardiology.

High-intensity statin effect independent of lipoprotein, CRP

November 13, 2014
(HealthDay)—High-intensity statin therapy is associated with coronary atherosclerosis regression, regardless of baseline lipoprotein or C-reactive protein (CRP) levels, according to a study published in the Nov. 15 issue ...

Many not treated according to 2013 cholesterol guidelines

November 25, 2014
(HealthDay)—Many patients are not being treated in accordance with the 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines, according to a study published in the Dec. 2 issue ...

Microsurgical head and neck reconstruction is cost-effective

December 16, 2016
(HealthDay)—For patients with squamous cell carcinoma (SCC), microsurgical head and neck reconstruction is cost-effective compared with locoregional flaps, according to a study published online Nov. 29 in Head & Neck.

Large variation in lipid reduction with high-dose statin tx

July 31, 2014
(HealthDay)—There is considerable interindividual variation in the magnitude of low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and apolipoprotein B (apoB) reductions achieved ...

Glucose variation impacts coronary plaque vulnerability

May 19, 2015
(HealthDay)—For patients with coronary artery disease (CAD) pretreated with lipid-lowering therapy, daily glucose fluctuation may affect coronary plaque vulnerability, according to a study published in the May issue of ...

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.